BridgeBio Pharma BBIO
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 76.49 | -2,087 | -214 | -22.12 | 936 | |
| 2025Q3 | 51.94 | -1,933 | -199 | -19.11 | 998 | |
| 2025Q2 | 43.18 | -1,788 | -202 | -20.60 | 1,080 | |
| 2025Q1 | 34.57 | -1,648 | -183 | -20.32 | 882 | |
| 2024Q4 | 27.44 | -1,468 | -282 | -35.57 | 919 | |
| 2024Q3 | 25.46 | -1,230 | -169 | -23.11 | 665 | |
| 2024Q2 | 25.33 | -1,093 | -81 | -9.90 | 794 | |
| 2024Q1 | 30.92 | -1,050 | -35 | -5.05 | 849 | |
| 2023Q4 | 40.37 | -1,354 | -168 | -27.99 | 546 | |
| 2023Q3 | 26.37 | -1,208 | -177 | -30.55 | 655 | |
| 2023Q2 | 17.20 | -1,362 | -158 | -27.96 | 504 | |
| 2023Q1 | 16.58 | -1,226 | -140 | -22.45 | 626 | |
| 2022Q4 | 7.62 | -1,255 | -138 | -20.36 | 623 | |
| 2022Q3 | 9.94 | -1,138 | -137 | -17.26 | 729 | |
| 2022Q2 | 9.08 | -1,026 | -10 | -1.18 | 862 | |
| 2022Q1 | 10.15 | -1,041 | -196 | -21.51 | 813 | |
| 2021Q4 | 16.68 | -870 | -147 | -16.40 | 1,013 | |
| 2021Q3 | 46.87 | -743 | -156 | -16.74 | 782 | |
| 2021Q2 | 60.96 | -464 | -96 | -8.86 | 1,081 | |
| 2021Q1 | 61.60 | -395 | -163 | -18.15 | 1,093 |